Tardive dyskinesia (TD) is a movement disorder caused by long-term use of certain drugs, accompanied by involuntary repetitive body movements, such as facial distortion, tongue sticking out or lip smacking. . These symptoms usually develop after treatment with antipsychotics or other neuroleptic drugs and may take months or years to develop. According to statistics, approximately 20% of TD patients will have difficulty functioning in their daily lives, while some patients may experience more serious conditions.
The diagnosis of tardive dyskinesia is usually based on observation of symptoms and exclusion of other potential causes.
The exact cause of tardive dyskinesia is not fully understood, but experts believe it may be caused by dopamine hypersensitivity caused by neuroleptic drugs. When prescribed neurological drugs, especially classical antipsychotics, patients' D2 dopamine receptors are particularly susceptible to being affected, which is one of the main factors leading to TD. Empirical studies have shown that long-term use of medications that trigger dopamine hypersensitivity may increase the risk of these symptoms.
The most obvious features of tardive dyskinesia are involuntary repetitive movements, including:
These movement disorders contrast sharply with the movement difficulties experienced by people with Parkinson's disease.
The diagnosis of tardive dyskinesia usually relies on careful observation of the patient's face. Doctors identify facial distortion, eye or lip movements, muscle spasms, and other involuntary movements and assess their severity.
The key to preventing tardive dyskinesia is to use the lowest effective dose of the neuroleptic agent and to keep the medication for as short a time as possible. If this condition is detected, consideration should be given to discontinuing the medication in question, although this may cause symptoms to become more severe in the short term. Experts recommend that lower-risk atypical antipsychotics be chosen instead of traditional drugs.
There is research supporting the use of vitamin E as a potential approach for prevention, but further empirical evidence is needed.
According to data, approximately 30% of antipsychotic users will develop tardive dyskinesia. Especially for elderly women, the risk is significantly higher than other groups and is closely related to the history of drug use. The latest research indicates that the use of second-generation antipsychotics reduces the risk of TD compared to traditional drugs, but caution should still be exercised regarding possible side effects.
In addition to the physical effects, people with tardive dyskinesia may experience social isolation and be at increased risk for body image problems, which may lead to suicidal feelings.
As awareness of tardive dyskinesia increases, patients and healthcare providers alike need to remain vigilant about this condition to ensure early recognition and appropriate treatment strategies. However, are you able to recognize these hidden symptoms and take the necessary actions to protect yourself and others from their impact?